Clinical Relevance: These data present a clinical correlate to the variable functional outcomes seen following surgical release of chronic nerve compression injuries and provide early support for using distal latency as a predictor of outcomes following surgical release.
C hronic nerve compression injuries such as carpal tunnel syndrome, cubital tunnel syndrome, and spinal nerve root stenosis result in morbidity with the possible loss of motor and sensory function, pain, paresthesia, and paralysis [1] [2] [3] . The effective therapeutic modalities for such injuries are currently strikingly limited to anti-inflammatory agents, corticosteroid injections, or surgical intervention 4 . Therefore, understanding the pathogenesis of such injuries is necessary to identify more successful treatment options.
Recent clinical data have shown that early surgical management of carpal tunnel syndrome has better efficacy and produces better long-term outcomes compared with more conservative medical approaches, such as injections, anti-inflammatory agents, and splinting [4] [5] [6] [7] . If surgical decompression is to be performed, it has been suggested that the timing of the surgery is also an important parameter for optimizing functional recovery 8 . Although surgical decompression often ameliorates the symptoms of carpal tunnel syndrome when performed early in the disease course by reversing the sensory dysfunction, there is limited understanding of why surgical intervention is less effective when performed at later time points and has limited effect on reversing the motor atrophy that develops later in the disease course 4, 5, 7, 9 . Currently, electrophysiology is considered important for making the diagnosis of carpal tunnel syndrome 10, 11 . In a study by Chandra et al., electrophysiological findings reversed after carpal tunnel release in both early surgery and delayed surgery groups 8 , but this is not always the case. In fact, many clinicians remain quite skeptical of the role of an electrophysiological examination in the management of patients suspected of having a compressive neuropathy. The American Academy of Orthopaedic Surgeons Clinical Guideline on the Diagnosis of Carpal Tunnel Syndrome provides a mixed endorsement of this examination on the basis of the varying levels of evidence supporting its use 12 .
Recent animal studies have provided data regarding the changes in blood flow following an acute nerve injury 13, 14 . Xu et al. found that epineurial red blood cell flux was reduced within one hour after a nerve crush injury, with a subsequent rebound hyperemia 13 , and Igarashi et al. also found a decrease in blood flow after a spinal nerve crush 14 . Although neurovascular flow after acute nerve injury has been studied, similar studies after chronic nerve compression injury are limited. Previous studies have shown that such chronic injuries are distinct from acute nerve injuries and have a fundamentally different pathogenesis in which Wallerian degeneration is not seen early after injury 15 . Although axonal pathology and degeneration are absent early after a chronic nerve compression injury, Schwann cells undergo concurrent processes of proliferation and apoptosis 15 . The compressed nerve has increased vascular permeability and neural vascularity with an upregulation of vascular endothelial growth factor (VEGF) and its Schwann cell receptors (fetal liver kinase receptor and fms-like tyrosine kinase receptor) at early time points, followed by a dramatic decrease [16] [17] [18] . Recent data have revealed that hypoxia potentiates the demyelinating effect of hydrostatic compression in an in vitro model of nerve compression injury 19 , but the role that ischemia plays in triggering the pathological responses in such an injury still remains unknown.
Patients with carpal tunnel syndrome have decreased blood flow in the median nerve, which is restored after release of the transverse carpal tunnel ligament 20 . These observations have led to the hypothesis that chronic nerve compression alters neural blood flow and induces ischemia in a fashion different from that in other neural injuries. The present study assesses the extent of the ischemia induced by chronic nerve compression and the ensuing changes in biochemical markers over time in a mouse model. In addition, this study assesses the effect of the timing of surgical decompression (early or late) on restoration of neurovascular flow, biochemical marker levels, and electrophysiological parameters.
Materials and Methods

Animal Model
A previously described model of chronic nerve compression was utilized 21 . Fifty-four six-week-old, male C57BL/6 mice (Harlan Laboratories, United Kingdom) were anesthetized by intraperitoneal injection of ketamine and xylazine and were divided equally into groups to be assessed two, four, and six weeks after chronic nerve compression injury. A dorsal gluteal-splitting approach was used to isolate and dissect each sciatic nerve free from the surrounding tissue. A 3-mm-diameter biologically inert Silastic tube (Cole-Parmer, Vernon Hills, Illinois) was placed atraumatically around the ipsilateral nerve below the level of the sciatic notch. Prior to surgery, all tubing had been placed in a Petri dish and soaked in 70% ethanol overnight, then allowed to dry in a vacuum hood, to minimize the inflammatory response. As previously detailed 21 , this procedure creates a chronic nerve compression injury that is defined by a progressive decline in nerve conduction velocity that plateaus at the six-week time point.
Two additional surgical cohorts of eighteen mice each were treated with early decompression, at two weeks after an identical injury, or with late decompression, at six weeks after injury 21 . Previous data have indicated that nerve conduction velocity exhibits a small decrease at two weeks after this injury and a large decrease at six weeks before plateauing 21 . Therefore, as these two time points represent the earliest and final changes seen after the chronic nerve compression injury, they were chosen to define the time points for early and late decompression. Decompression was performed by atraumatically removing the inert tubing from the nerve.
A separate cohort of ten mice that received a crush injury served as positive controls for demonstrating a decrease in neural blood flow. The right sciatic nerve was carefully exposed, mobilized, and crushed immediately distal to its emergence from the gluteus maximus with use of hemostatic forceps for thirty seconds 22 . Thus, nerves in six groups totaling 100 mice were used in the study (Table I) . A power analysis was performed prior to the study to estimate the group sizes needed to achieve significance in the various experiments. All procedures involving living animals were approved by the Institutional Animal Care and Use Committee of the University of California, Irvine.
Electrodiagnostic Evaluation
Nerve conduction velocity was measured in all animals preoperatively and serially at weekly time points, by a board-certified neurologist with clinical expertise in neuromuscular diseases and extensive research experience with rats and mice, until the nerves were harvested. Recordings of both the ipsilateral experimental and contralateral limbs were made in vivo under ketamine and xylazine anesthesia on an electromyography instrument (Sierra LT; Cadwell Laboratories, Kennewick, Washington). Motor conduction at the sciatic and tibial nerves was assessed by stimulation at the sciatic notch and knee with use of a monopolar needle electrode. The reference for the stimulating electrode was placed in the ipsilateral lumbar paraspinal muscle. The compound muscle action potential of the ankle dorsiflexion muscle (tibialis anterior) innervated by the tibial nerve was recorded by placing subdermal electroencephalographic electrodes in the muscle approximately 2 mm above the heel. The reference recording electrode was inserted into the dorsal aspect of the foot, and the amplitude of the compound muscle action potential and the motor nerve conduction velocity were measured.
Laser Speckle Imaging
Laser speckle imaging was used to measure neurovascular blood flow 23 . This is a previously described, noninvasive technique for studying the motion of optically scattering materials with high spatial and temporal resolution 24 . Light from a 785-nm continuous-wave diode laser (B&W Tek, Newark, Delaware) was delivered to the target with an optical fiber and diverged with a ground-glass diffuser (Thorlabs, Newton, New Jersey). Reflected speckle patterns were imaged with an 8-bit CCD (charge-coupled device) camera (A602f; Basler, Exton, Pennsylvania) equipped with a macro lens. Images were transferred to a laptop computer in real time via the FireWire 400 interface. Processing and rendering of the speckle flow index (SFI) images was performed with use of custom-written software developed in LabVIEW (National Instruments, Austin, Texas).
The laser speckle imaging was performed at two, four, and six weeks after injury in the no-decompression groups and at one, two, and three weeks after treatment in the decompression groups. Imaging in the positive controls that received a crush injury was performed at baseline, every twenty minutes for the first three hours, and at one day and one and two weeks.
Western Blotting
The markers of interest were hypoxia-inducible factor (HIF)1a , matrix metalloproteinases (MMPs) 2 and 9, superoxide dismutase (SOD), and catalase. The primary antibodies used were rabbit anti-HIF1a (1:1000 dilution; Novus Biologicals, Littleton, Colorado), mouse anti-MMP9 (1:5000 dilution; Abcam, Cambridge, Massachusetts), rabbit anti-MMP2 (1:5000 dilution; abcam), rabbit anti-superoxide dismutase (1:5000 dilution; Sigma-Aldrich, St. Louis, Missouri), mouse anti-catalase (1:5000 dilution; Sigma-Aldrich), mouse anti-GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (1:50,000 dilution; Fitzgerald, Acton, Massachusetts), and mouse anti-tubulin (1:10,000 dilution, Sigma-Aldrich) 19, [25] [26] [27] [28] [29] [30] [31] . The western blotting procedure was performed at two, four, and six weeks after injury in the no-decompression groups as well as at two and six weeks after treatment in the decompression groups. Both the ipsilateral (experimental) nerve and the contralateral nerve were harvested and homogenized completely. Each sample was centrifuged at 14,000 rpm for ten minutes to remove fibrotic remnants of the nerve, and the protein concentration in the resultant whole-tissue lysate was determined with use of a BCA Protein Assay Kit (Thermo Scientific, Rockford, Illinois). Briefly, 75 to 100 mg of protein was separated by 8% or 10% SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis), transferred to nitrocellulose membrane, blocked with 5% dry skimmed milk, and incubated overnight at 4°C with primary antibodies. Donkey anti-mouse secondary antibody conjugated with horseradish peroxidase (HRP, 1:10,000 dilution; EMD Millipore, Billerica, Massachusetts) or goat anti-rabbit secondary antibody conjugated with HRP (1:10,000 dilution) was used for detection 19, 25 . Blot development was performed with Immobilon
Western Chemiluminescent HRP Substrate (Millipore). Films were digitized with use of a color scanner and analyzed with use of MetaMorph image analysis showed a progressive decline until six weeks after injury; the normal nerve remained unchanged. Fig. 1 -B Distal latency was prolonged after CNC injury. **P < 0.01. ***P < 0.001. ****P < 0.0001. Six-week CNC injury 18
Decompression after two weeks of CNC injury 18
Decompression after six weeks of CNC injury 18 *CNC = chronic nerve compression.
software (Molecular Devices, Sunnyvale, California). Quantitative results were calculated by normalizing the densitometry data for each antibody with respect to that of b-tubulin or GAPDH on the same blot.
Statistical Analysis
Data are presented as the mean and standard error along with the 95% confidence interval (CI). One-way analysis of variance with Bonferroni post hoc comparison was performed unless otherwise indicated. A p value of <0.05 was considered significant. 
Source of Funding
Results
Sustained Decreases in Nerve Conduction Velocity After Injury
N ormal and uninjured wild-type sciatic nerves that had been mobilized but not compressed maintained a baseline nerve conduction velocity of 51.5 ± 1.6 m/sec, consistent with that in previous studies 21 . After creation of a chronic nerve compression injury, the velocity declined progressively to 37.5 ± 2.5 m/sec at six weeks after injury (Fig. 1-A) . The amplitude of injury, blood flow in the sciatic nerve (at the crush site as well as distal to it) decreased immediately and eventually returned to a hyperemic state after several days. Fig. 2 -B CNC injury was followed by a distinctly different pattern of neurovascular changes, with an initial period of hyperemia followed by a marked decline in flow. Figs. 3-A through 3-F Western blot analysis of normal, uninjured nerves (N) and nerves after two, four, and six weeks of chronic nerve compression (CNC) injury. The densitometry for the markers in Fig. 3 -A is plotted in the remaining panels as the mean and standard error. *P < 0.05. **P < 0.01. A.U. = arbitrary units. Fig. 3 -A Western blot bands for the cellular hypoxic markers and for the GAPDH reference. Fig. 3 -B The HIF1a level was elevated early after CNC injury. Fig. 3 -C The MMP2 level was elevated later after injury. Fig. 3 -D The catalase level was elevated early after injury, and the elevation persisted longer than it did for HIF1a. Fig. 3 -E The MMP9 level was elevated at four and six weeks after injury. Fig. 3 -F The SOD level was elevated at four weeks after injury.
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the compound muscle action potential was assessed to confirm that this decline resulted primarily from demyelination of the sciatic nerves rather than from axonal pathology and damage 21 . Consistent with previous experiments 21 , no significant difference was observed between the amplitudes in compressed and uncompressed nerves. Distal latency increased as early as two weeks after creation of a chronic nerve compression injury and remained elevated (1.13 ± 0.05 msec at six weeks compared with 1.32 ± 0.07 msec [95% CI = 1.17 to 1.47 msec] at two weeks, p = 0.007) (Fig. 1-B) .
Decreased Neural Blood Flow After Injury
Laser speckle imaging was used to assess neural blood flow in the sciatic nerve. Imaging performed in mice that received a crush injury (the positive controls) confirmed the decline in neural blood flow; similar to previously reported results 13 , the blood flow in the sciatic nerve decreased immediately after the crush and returned to baseline by one week after injury (Fig. 2-A) . In the mice in which a chronic nerve compression injury was created, baseline values of neural blood flow were measured in both the experimental and contralateral, control nerves prior to placement of the inert tube. The measurements were repeated at two, four, and six weeks after injury to determine the level of hypoxia that was induced. In contrast to the immediate decrease in blood flow observed after the neural crush injury, chronic nerve compression injury initially created a period of hyperemia (1.37 ± 0.50 times that in the contralateral, uninjured nerve at the same time point), although the difference between the treatments did not reach significance. However, this initial hyperemia was then followed by a drastic decline in blood flow through the nerve to 0.66 ± 0.14 (95% CI = 0.51 to 0.80) at four weeks (p = 0.0313), and the lower value was maintained over time ( Fig. 2-B) . Raw speckle images showing blood flow through the nerve are also shown in Figure 2 .
Alterations in Cellular Markers of Hypoxia After Injury
The level of HIF1a increased after two weeks of compression (from 1.00 ± 0.04 to 2.25 ± 0.20 [95% CI = 1.40 to 3.11], p = 0.0035), followed by a dramatic decline by six weeks (Figs. 3-A  and 3-B) . Catalase also increased after two weeks of compression (from 0. MMP9 was elevated after four weeks of compression (from 1.04 ± 0.04 to 2.07 ± 0.15 [95% CI =1.74 to 2.40], p < 0.05) and remained elevated at the six-week time point (2.12 ± 0.34, 95% CI = 1.38 to 2.86) (Figs. 3-A and 3-E) . MMP2, which is involved in the regulation of vascularization, also showed an elevation 
Early but Not Late Surgical Decompression Reversed Deleterious Hypoxic Changes
Nerve conduction velocity returned to baseline by two weeks after both early decompression (performed two weeks after injury) and late decompression (performed six weeks after injury) (52.90 ± 0.69 and 53.60 ± 0.90 m/sec, respectively) (Figs. 4-A and 4-B) . Distal latency returned to baseline after early decompression was performed (0.97 ± 0.06 msec at four weeks) but not after late decompression (1.22 ± 0.06 msec [95% CI = 1.10 to 1.35 msec] at four weeks, p = 0.009) (Figs. 4-C and  4-D) . Thus, even though nerve conduction velocity returned to normal after late decompression, distal latency did not.
Neurovascular flow dynamics, as assessed with laser speckle imaging at one, two, and three weeks after decompression, showed a pattern similar to that of distal latency. Neural blood flow after early decompression showed a progressive rebound to a hyperemic state that exceeded the original baseline value within three weeks (1.35 ± 0.16 [95% CI = 1.10 to 1.60] times that in the contralateral nerve at the same time point, p = 0.0057) (Figs. 5-A, 5-C, and 5-D) . However, neural blood flow after late surgical decompression failed to return to the Figs. 5-A through 5-E Neurovascular blood flow changes at one, two, and three weeks after surgical decompression (dCNC) of a chronic nerve compression injury.
Figs. 5-A and 5-B Blood in the nerve rebounded to a hyperemic state within three weeks after early decompression but remained below the baseline value after late decompression was performed. The mean and standard error are plotted. **P < 0.01. N = normal (uninjured) nerve. Figs. 6-A through 6-F Western blot analysis of normal, uninjured nerves (N) and nerves six weeks after early and late decompression (dCNC) of a chronic nerve compression (CNC) injury. The densitometry for the markers in Fig. 6 -A is plotted in the remaining panels as the mean and standard error. *P < 0.05.
A.U. = arbitrary units. Fig. 6 -A Western blot bands for the cellular hypoxic markers HIF1a, catalase, SOD, MMP2, and MMP9 and for the GAPDH reference. Fig. 6 -B HIF1a remained elevated after early decompression but not after late decompression. Fig. 6 -C MMP2 levels were unchanged after decompression. Fig. 6 -D Catalase levels followed a pattern similar to HIF1a, with elevation after early decompression. Fig. 6 -E MMP9 remained elevated after late decompression. Fig. 6 -F SOD levels were unchanged.
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T , there remains limited understanding regarding the biochemical changes that occur after surgical intervention. Moreover, surgical intervention often results in limited or no reversal of the related motor atrophy as well as variable changes in the electrophysiological parameters. The present study provided new data to better understand the cellular and molecular changes after chronic nerve compression injury. Although there is considerable evidence suggesting a dramatic decrease in blood flow immediately following a neural injury such as a crush injury 13, 14 , the studies characterizing the changes in hypoxia seen after a chronic nerve compression injury are quite limited. The present study revealed that a chronic nerve compression injury results in a gradual decline in neurovascular blood flow to a new plateau, which contrasts with the changes seen after a crush injury. It also revealed attempts by the peripheral nerve to compensate for the decrease in blood flow caused by the mechanical forces and stresses resulting from the chronic nerve compression injury. These attempts are reflected by the elevated cellular levels of hypoxic markers such as HIF1a, catalase, and MMP9. HIF1a, a transcriptional regulator of hypoxia-inducible genes, induces angiogenesis to increase oxygen delivery when a low oxygen tension is present. MMP9 likely serves to break down the extracellular matrix and remodel tissue in the Schwann cell basal lamina to aid the peripheral nerve in establishing its new baseline blood flow after the chronic nerve compression injury.
Recent advancements in the understanding of compressive neuropathies suggest that a chronic nerve compression state may actually represent a form of chronic neural wound-healing 33 . Classically, wound-healing is a well-described biological phenomenon consisting of inflammation, cellular proliferation, angiogenesis, and connective tissue remodeling 34 . We previously demonstrated the prevalence of tissue inflammation, as indicated by upregulation of TNFa (tumor necrosis factor a), proliferation of Schwann cells and fibroblasts, altered neural vasculature, and connective tissue remodeling, during the progression of a chronic nerve compression injury 33 . The results of that study support the concept that chronic nerve compression creates a neural scar that alters the neural blood flow, as seen in the previous and present experiments.
Hypoxic conditions induce expression of VEGF and other molecules in the nervous system of adults rodents, both in vitro and in vivo 35, 36 . Ischemia augments transcription via upregulation of transcriptional factors known as hypoxia-inducible factors. VEGF production results in improved oxygen delivery to the compressed region of the nerve. The presence of excess oxygen causes the formation of free radicals in the compressed nerve and its associated Schwann cells, and the free radicals are likely neutralized through the production of superoxide dismutases and catalase. HIF1a is located upstream of VEGF, superoxide dismutase, and catalase and induces their production once hypoxia occurs. Enhanced production of these molecules by Schwann cells has been reported previously and suggests that neovascularization occurs secondary to chronic nerve compression 18 . The elevation of HIF1a and catalase early in the disease process corresponds to the hyperemia seen initially. Furthermore, if these molecular markers are still elevated at the time of surgical decompression, it can be inferred that neurovascular blood flow can be restored by removal of the offending compression and increased angiogenesis. However, once the matrix metalloproteinases are activated, it appears that the hypoxic changes have progressed and permanent pathogenesis has begun, as evidenced by the data presented here.
Seiler et al. performed carpal tunnel release of the median nerve in patients and showed that median nerve blood flow became pulsatile and synchronized with the patient's pulse within one minute after release of the transverse carpal ligament, implying that the blood flow in these patients had been compromised 20 . Although such early clinical data exist, we are aware of no relevant previous data regarding what happens to neural blood flow after the surgical intervention is completed. The present study of chronic nerve compression injury in a mouse model suggests that the deleterious hypoxic changes can be reversed if surgical decompression is performed at two weeks after the injury but not at six weeks; the changes in blood flow are permanent in the latter case, implying that there is a time point beyond which the surgical intervention may have limited value. Additional studies analyzing blood vessel formation are needed to understand the molecular mechanisms by which surgical decompression offers better outcomes than more conservative treatment options.
Performing an early surgical decompression offers the optimal treatment option for patients with a nerve compression injury 8 . Although the relevant time frames may differ between murine and human nerve injuries, the timing of the corresponding changes in molecular markers in human subjects can be used as a basis for establishing the proper time frame for clinical intervention. Furthermore, this approach should be applicable to compression of a variety of nerves including the median nerve, ulnar nerve, or spinal nerve roots in human patients, as the changes at the cellular and molecular levels are expected to be similar to those for compression of the sciatic nerve in our murine model. Electrophysiological studies are a tool for making the diagnosis of carpal tunnel syndrome in patients 10, 11 . As carpal tunnel syndrome represents a distal demyelination syndrome, prolongation of distal latency may be a more sensitive measure of carpal tunnel syndrome than median nerve conduction velocity, which may not be affected in the measured segment [37] [38] [39] [40] . Our study revealed that distal latency persisted after surgical decompression performed at six weeks but actually returned to the normal range after decompression performed at two weeks. The data for the group treated with decompression at six weeks after injury suggest that distal latency may be a more sensitive and specific measure for predicting patient outcomes after surgical release than the routine use of nerve conduction velocity values alone. Most importantly, these data support previous reports of the importance of early surgical intervention in providing optimal treatment for nerve compression syndromes 8 . n
